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General Notes 
 All synthetic procedures containing chromium were performed in a nitrogen-atmosphere 
glove box or in sealed containers under a stream of nitrogen gas. All glassware was oven-dried 
and kept under active vacuum prior to use. Diethyl ether, tetrahydrofuran (THF), toluene, 
dichloromethane (DCM), hexanes, and pentane solvents were purified by sparging with nitrogen 
and then passing through a column of activated A2 alumina into sealed containers, degassed 
under active vacuum and stored over activated molecular sieves prior to use. 1,4-Dioxane was 
dried over Na/benzophenone, vacuum distilled and kept over activated molecular sieves prior to 
use. Chlorobenzene was distilled from CaH2, stored over activated molecular sieves for at least 
24 hours, and filtered through activated alumina directly before use. CD2Cl2 (Cambridge Isotope 
Laboratories) was distilled from CaH2 and kept over activated molecular sieves prior to use. M-
MAO 3A was purchased from AkzoNobel as a 7% w/w Al solution in heptane. Ethylene gas was 
purchased at polymer purity (99.9%) from Matheson, and was dried by passage through two 1L 
Swagelok steel columns packed with 3Å activated molecular sieves and Mn(II) oxide on 
vermiculite.1 CrCl3(THF)3 was synthesized according to the literature procedure, using CrCl3 
(anhydrous) purchased from Strem.2 The synthesis of iPrPNP, and [H(Et2O)2][BAr′4] have been 
previously reported.3,4 2-Bromoanisole was purchased from Sigma-Aldrich and distilled before 
use. The other ether-based aryl bromides were synthesized by methylation or benzylation of the 
corresponding alcohols, according to the literature procedures,5-7 and dried under vacuum before 
use. N-(2-bromobenzyl)-N-ethylethanamine was synthesized as reported.8 Paramagnetic 
susceptibility values (µeff) were determined by NMR (Evans’ method).9,10 Evans’ method was 
performed by dissolving the compound in CD2Cl2 solvent (with added protio solvent as the 
reference). The NMR tube contained a capillary insert with blank CD2Cl2:CH2Cl2 of the same 
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composition inside. NMR spectra were recorded on a Varian 300 MHz or 400 MHz 
Spectrometer. UV/Vis spectra were obtained on a Varian Cary Bio 50 spectrophotometer. EPR 
spectra were obtained by freezing 1:1 toluene:dichloromethane solutions of [Cr] = 4 mM, using a 
Bruker EMX spectrometer. Elemental analysis was performed using a PerkinElmer 2400 Series 
II CHN Elemental Analyzer. Gas chromatography (GC) was performed on an Agilent 6890A 
instrument using a DB-1 capillary column (10 m length, 0.10 mm diameter, 0.40 µm film) and a 
flame ionization detector. Gas chromatography/mass spectrometry (GC-MS) was performed on 
an Agilent 6890A instrument using a HP-5MS column (30 m length, 0.25 mm diameter, 0.50 µm 
film) and an Agilent 5973N mass-selective EI detector. 
 
X-Ray Crystallography 
Suitable crystals of complexes 1, 2, 3, 3′, 4, and 5 were mounted on a nylon loop using 
Paratone oil, then placed on a diffractometer under a nitrogen stream. X-ray intensity data were 
collected on a Bruker APEXII CCD area detector or a Bruker D8 VENTURE Kappa Duo 
PHOTON 100 CMOS detector employing Mo-Kα radiation (λ = 0.71073 Å) or Cu-Kα radiation 
(λ = 1.54178 Å) at a temperature of 100 K. All diffractometer manipulations, including data 
collection, integration and scaling were carried out using the Bruker APEX3 software.11 In 
APEX3, intensity data were absorption-corrected using SADABS, and space groups were 
determined on the basis of systematic absences and intensity statistics using XPREP. Using 
Olex2, the structures were solved using ShelXT and refined to convergence by full-matrix least 
squares minimization.12,13 All non-hydrogen atoms were refined using anisotropic displacement 
parameters. Hydrogen atoms were placed in idealized positions and refined using a riding model. 
In complex 3, solvent disorder from a combination of 3.4 CH2Cl2 and/or pentane molecules (42 
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electrons each) was treated by SQUEEZE/PLATON. Crystals of complex 3′ were obtained by 
the same route as complex 3, but THF was the solvent of crystallization, rather than CH2Cl2; the 
molecular structure is shown in Figure S1. In complex 3′, the disorder in the ethereal ligand 
bound to Cr was modeled as a mixture of THF and 1,4-dioxane using the PART instruction (1,4-
dioxane was also used in the synthetic protocol) and C-C bond distance constraints and 
restraints. For complex 5, the disorder in five of the eight CF3 groups of the BAr′4 anion was 
modeled using the PART instruction and bond distance and anisotropic displacement parameter 
restraints. In complex 5, the CH2Cl2 solvent disorder was modeled using the EQIV instruction, 
placing half of a molecule of CH2Cl2 in the asymmetric unit. Graphical representation  of  
structures  with  50%  probability  thermal  ellipsoids  were generated  using  Diamond 3 
visualization software.14  
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Table S1. Crystal and Refinement Data for Complexes 1 and 2.   
Compound 1 2 
CCDC 1895679 1895680 
Empirical formula C42H39CrO3 C45H45CrO3 
Formula weight 643.73 685.81 
Temperature/K 99.97 99.99 
Crystal system triclinic monoclinic 
Space group P-1 P21/c 
a/Å 10.7286(4) 11.5802(10) 
b/Å 11.7519(4) 15.8845(12) 
c/Å 15.0753(5) 20.0281(17) 
α/° 95.481(2) 90 
β/° 102.260(2) 103.123(3) 
γ/° 115.318(2) 90 
Volume/Å3 1641.19(11) 3587.9(5) 
Z 2 4 
ρcalcg/cm3 1.303 1.270 
µ/mm-1 3.170 0.359 
F(000) 678 1452 
Crystal size/mm3 0.166 × 0.14 × 0.086 0.314 × 0.245 × 0.22 
Radiation CuKα (λ = 1.54178) MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.14 to 136.72 4.902 to 72.626 
Index ranges -12 ≤ h ≤ 12, -14 ≤ k ≤ 14, -18 ≤ l ≤ 18 
-19 ≤ h ≤ 19, -26 ≤ k ≤ 
26, -33 ≤ l ≤ 33 
Reflections collected 44667 210362 
Independent reflections 6047 [Rint = 0.0679, Rsigma = 0.0454] 
17385 [Rint = 0.0701, 
Rsigma = 0.0305] 
Data/restraints/parameters 6047/0/415 17385/0/442 
Goodness-of-fit on F2 1.041 1.059 
Final R indexes [I>=2σ (I)] R1 = 0.0493, wR2 = 0.0983 
R1 = 0.0409, wR2 = 
0.1106 
Final R indexes [all data]  R1 = 0.0685, wR2 = 0.1061 
R1 = 0.0594, wR2 = 
0.1225 
Largest diff. peak/hole / e Å-3 0.300/-0.472  0.703/-0.619 
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Table S2. Crystal and Refinement Data for Complexes 3 and 3′.   
Compound 3 3′ 
CCDC 1895681 1895682 
Empirical formula C21H21CrO3 C25H29CrO4.58 
Formula weight 373.38 454.80 
Temperature/K 100.0 100.05 
Crystal system triclinic monoclinic 
Space group P-1 Cc 
a/Å 12.0150(16) 20.0935(10) 
b/Å 12.4851(16) 11.1921(6) 
c/Å 15.1703(19) 10.9889(5) 
α/° 75.513(5) 90 
β/° 87.541(5) 116.859(2) 
γ/° 80.203(5) 90 
Volume/Å3 2171.2(5) 2204.68(19) 
Z 4 4 
ρcalcg/cm3 1.142 1.370 
µ/mm-1 0.540 0.551 
F(000) 780 959 
Crystal size/mm3 0.252 × 0.179 × 0.125 0.406 × 0.168 × 0.108 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.42 to 66.342 6.650 to 72.734 
Index ranges -17 ≤ h ≤ 18, -19 ≤ k ≤ 19, -23 ≤ l ≤ 22 
-33 ≤ h ≤ 33, -18 ≤ k ≤ 
18, -18 ≤ l ≤ 18 
Reflections collected 102156 60629 
Independent reflections 14945 [Rint = 0.0687, Rsigma = 0.0569] 
10655 [Rint = 0.0585, 
Rsigma = 0.0405] 
Data/restraints/parameters 14945/0/457 10655/10/320 
Goodness-of-fit on F2 1.039 1.028 
Final R indexes [I>=2σ (I)] R1 = 0.0610, wR2 = 0.1147 
R1 = 0.0310, wR2 = 
0.0730 
Final R indexes [all data]  R1 = 0.0897, wR2 = 0.1247 
R1 = 0.0366, wR2 = 
0.0750 
Largest diff. peak/hole / e Å-3 0.696/-0.613  0.667/-0.493 
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Table S3. Crystal and Refinement Data for Complexes 4 and 5.   
Compound 4 5 
CCDC 1895683 1895684 
Empirical formula C27H33CrO3 C77.5H62BClCrF24NO2P2 
Formula weight 457.53 1655.48 
Temperature/K 100.09 100.01 
Crystal system monoclinic triclinic  
Space group P21/n P-1 
a/Å 8.3974(4) 12.9268(7) 
b/Å 22.6187(10) 16.7595(10) 
c/Å 12.1007(5) 18.9950(9) 
α/° 90 104.445(2) 
β/° 92.754(2) 96.510(2) 
γ/° 90 107.746(2) 
Volume/Å3 2295.73(18) 3714.6(4) 
Z 4 2 
ρcalcg/cm3 1.324 1.48 
µ/mm-1 0.524 0.341 
F(000) 972 1684 
Crystal size/mm3 0.198 × 0.143 × 0.133 0.2 × 0.15 × 0.1 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 5.778 to 72.716 4.526 to 67.496 
Index ranges -13 ≤ h ≤ 13, -37≤ k ≤ 37, -19 ≤ l ≤ 20 
-20 ≤ h ≤ 20, -26 ≤ k ≤ 
25, -29 ≤ l ≤ 29 
Reflections collected 87691 199425 
Independent reflections 11083 [Rint = 0.0548, Rsigma = 0.0363] 
29673 [Rint = 0.0508, 
Rsigma = 0.0379] 
Data/restraints/parameters 11083/0/283 29673/369/1135 
Goodness-of-fit on F2 1.065 1.100 
Final R indexes [I>=2σ (I)] R1 = 0.0444, wR2 = 0.0987 
R1 = 0.0621, wR2 = 
0.1413 
Final R indexes [all data]  R1 = 0.0631, wR2 = 0.1056 
R1 = 0.0808, wR2 = 
0.1500 
Largest diff. peak/hole / e Å-3 1.357/-0.488  1.197/-2.170 
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Figure S1. Solid-state structure of complex 3′, which is obtained by following the synthetic 
protocol for 3, yet growing crystals in THF. The coordinated ethereal ligand is modeled as a 
mixture of THF/1,4-dioxane (1,4-dioxane is used in the synthesis of 3/3′). 
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Figure S2. Paramagnetic 1H NMR spectra. Each sample is prepared in CD2Cl2 with [Cr] ≈ 100 
mM. 
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Figure S3. Continuous wave (cw) EPR spectrum of compound 1. Temperature: 77K. Microwave 
frequency: 9.4 GHz.  Microwave power: 6.4 mW. Modulation frequency: 100 kHz. Modulation 
amplitude: 4.0 G. 
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Figure S4. Continuous wave (cw) EPR spectrum of compound 2. Temperature: 77K. Microwave 
frequency: 9.4 GHz.  Microwave power: 6.4 mW. Modulation frequency: 100 kHz. Modulation 
amplitude: 4.0 G. 
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Figure S5. Continuous wave (cw) EPR spectrum of compound 3. Temperature: 77K. Microwave 
frequency: 9.4 GHz.  Microwave power: 6.4 mW. Modulation frequency: 100 kHz. Modulation 
amplitude: 4.0 G. 
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Figure S6. Continuous wave (cw) EPR spectrum of compound 4. Temperature: 77K. Microwave 
frequency: 9.4 GHz.  Microwave power: 6.4 mW. Modulation frequency: 100 kHz. Modulation 
amplitude: 4.0 G. 
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Figure S7. Continuous wave (cw) EPR spectrum of compound 5. Temperature: 77K. Microwave 
frequency: 9.4 GHz.  Microwave power: 6.4 mW. Modulation frequency: 100 kHz. Modulation 
amplitude: 4.0 G. 
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